Circulating biomarkers further support the presence of vascular damage, as SMA patients exhibit elevated circulating endothelial cells (CEC) and reduced endothelial progenitors, which correlate with both disease severity and SMN2 copy number [14, 19, 73]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.